Trading Signals
Urovant Sciences (UROV)’ Largest Shareholder set to Acquire UROV for $584 Million
Sumitovant Biopharma, the largest shareholder of Urovant already owns 72% of the company and is now set to acquire it entirely. Shares of Urovant Sciences Ltd. (UROV) spiked on Friday after the company announced the acquisition deal with Sumitovant Biopharma. UROV soared up to 93.48% trading
